PNC Financial Services Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.9M | Sell |
|
|||||
|
2025
Q1 | $37.9M | Sell |
|
|||||
|
2024
Q4 | $31.7M | Sell |
|
|||||
|
2024
Q3 | $36.9M | Buy |
|
|||||
|
2024
Q2 | $35.2M | Sell |
|
|||||
|
2024
Q1 | $33.4M | Buy |
|
|||||
|
2023
Q4 | $31.2M | Buy |
|
|||||
|
2023
Q3 | $25.8M | Buy |
|
|||||
|
2023
Q2 | $25.6M | Buy |
|
|||||
|
2023
Q1 | $21.5M | Sell |
|
|||||
|
2022
Q4 | $20.3M | Sell |
|
|||||
|
2022
Q3 | $21M | Buy |
|
|||||
|
2022
Q2 | $20.1M | Buy |
|
|||||
|
2022
Q1 | $18.6M | Buy |
|
|||||
|
2021
Q4 | $11.3M | Buy |
|
|||||
|
2021
Q3 | $5.65M | Buy |
|
|||||
|
2021
Q2 | $5.97M | Sell |
|
|||||
|
2021
Q1 | $6.39M | Sell |
|
|||||
|
2020
Q4 | $10.8M | Sell |
|
|||||
|
2020
Q3 | $12.9M | Buy |
|
|||||
|
2020
Q2 | $13.3M | Buy |
|
|||||
|
2020
Q1 | $5.77M | Buy |
|
|||||
|
2019
Q4 | $5.12M | Buy |
|
|||||
|
2019
Q3 | $3.96M | Sell |
|
|||||
|
2019
Q2 | $4.58M | Sell |
|
|||||
|
2019
Q1 | $4.79M | Buy |
|
|||||
|
2018
Q4 | $4.12M | Sell |
|
|||||
|
2018
Q3 | $6.12M | Buy |
|
|||||
|
2018
Q2 | $3.92M | Sell |
|
|||||
|
2018
Q1 | $4.05M | Buy |
|
|||||
|
2017
Q4 | $3.56M | Sell |
|
|||||
|
2017
Q3 | $3.94M | Buy |
|
|||||
|
2017
Q2 | $2.9M | Buy |
|
|||||
|
2017
Q1 | $2.3M | Buy |
|
|||||
|
2016
Q4 | $1.29M | Sell |
|
|||||
|
2016
Q3 | $2.1M | Buy |
|
|||||
|
2016
Q2 | $1.81M | Buy |
|
|||||
|
2016
Q1 | $1.34M | Buy |
|
|||||
|
2015
Q4 | $1.73M | Sell |
|
|||||
|
2015
Q3 | $3.78M | Buy |
|
|||||
|
2015
Q2 | $4.35M | Sell |
|
|||||
|
2015
Q1 | $4.26M | Buy |
|
|||||
|
2014
Q4 | $4.04M | Buy |
|
|||||
|
2014
Q3 | $3.15M | Buy |
|
|||||
|
2014
Q2 | $1.41M | Sell |
|
|||||
|
2014
Q1 | $1.08M | Sell |
|
|||||
|
2013
Q4 | $1.31M | Sell |
|
|||||
|
2013
Q3 | $1.59M | Buy |
|
|||||
|
2013
Q2 | $1.45M | Buy |
|